Acetylcysteine inhalation to prevent pneumonia in ventilated patients
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests if breathing in a medication called acetylcysteine can help prevent lung infections in patients who are on a breathing machine. If you or a loved one is on a ventilator, this treatment might reduce the chance of getting ventilator-associated pneumonia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You are critically ill and on a breathing machine (ventilator).
- Doctors expect you to need the ventilator for more than 48 hours.
- Your next of kin has agreed to the study for you.
- You are not pregnant, and you do not have a current lung infection or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a simple oral suctioning routine can lower the risk of ventilator-associated pneumonia in ICU patients. Your loved one may be able to join if they need a breathing tube and do not have a serious lung infection or a weakened immune system.
This study tests if careful management of the pressure in the breathing tube's cuff and regular cleaning below the vocal cords can help prevent lung infections in people who need a breathing machine for a long time. It might help if you're at risk for stomach contents or saliva going into your lungs.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This trial tests if taking N-acetylcysteine (NAC) alongside standard TB treatment can help prevent long-term lung problems after tuberculosis. It is for people with moderate to severe TB who already have some reduced lung function.
This trial tests if N-acetylcysteine, a medicine that helps the liver and fights inflammation, can improve outcomes for adults with a severe infection and liver stress.
This trial tests a new way of using a ventilator (TCAV) versus standard care for people with moderate-to-severe lung failure caused by community-acquired pneumonia. It aims to see if this approach can improve outcomes.
Hear when a new Ventilation Acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.